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3/J-Hydroxysteroid dehydrogenase .14-5-isomerase (.15-
3/J-HSD) catalyzes an early step in the synthesis of t es-
tosterone from dehydroepiandrosterone (DHA). We 
compared enzyme activity in back skin biopsies with 
sebum excretion rate (SER) in 14 individuals. The rate of 
conversion of [7a-3H]DHA into [3H]-4-androstene-3,17-
dione was measured in cryostat sections of skin and 
compared with the sebaceous gland content of the same 
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DHA: dehydroepiandrosterone 
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SER: sebum excretion rate 
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biopsies. Reaction rate was proportional t o the volume 
of sebaceous gland tissue in the sections . Enzyme activ -
ity was absent from sections without histologically iden-
tifiable sebaceous gland tissue. This suggests that the 
~5-3/J-HSD is localized in sebaceous glands. SER, m eas-
ured by a modified photometric technique at the biopsy 
site, correlated highly with sebaceous gland volume and 
with the rate of conversion of DHA into androstenedione 
in the biopsy. For each biopsy, specific activity of .15-3/J-
HSD in sebaceous glands was calculated by dividing the 
rate of formation of PH]-4-androstene-3,17 -dione by se-
baceous gland volume. Specific activity of ~5-3/J-HSD did 
not correlate significantly with SER, suggesting that 
variations in concentration of ~5-3/J-HSD in sebaceous 
glands probably do not underlie variations in sebaceous 
gland activity. 
The weak androgen dehydroepiandrosterone (DHA) stimu-
lates sebaceous gland secretion in humans [1,2]. The increase 
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TABLE I. Details of patients 
No. Sex Age Grade of acne SER (~/cm'/3 h) 
1 F 20 Mild 14.2 
2 F 21 Mild 36.5 
3 F 21 Mild 26.0 
4 F 22 Mild 18.3 
5 F 28 Moderate 15.5 
6 F 28 Moderate 12.25 
7 F 29 Moderate 27.5 
8 M 18 Severe 33.0 
9 M 18 Severe Unobtainable 
10 M 18 Moderate 11.8 
11 M 19 Mild 17.2 
12 M 21 Moderate 35.2 
13 M 21 Moderate 24.7 
14 M 31 Moderate 16.4 
in its plasma concentration in early puberty [3,4] is associated 
with an increase in sebaceous gland size and secretory activity 
[5,6] and could be a cause of acne [7]. DHA is converted into 
the potent androgens, testosterone and 5a-dihydrotestosterone, 
in human skin (8]. The activity of the 3,8-hydroxysteroid de-
hydrogenase .14- 5-isomerase (.15-3/3-HSD) enzyme complex, 
which catalyzes an early step in this pathway, might influence 
the level of "active androgen" in sebaceous glands, thereby 
controlling sebum secretion [9-13]. In order to test this hypoth-
esis, we compared the activity of .15-3,8-HSD in human seba-
ceous glands with the in vivo secretory activity of the same 
glands. 
MATERIALS AND METHODS 
Patients and Clinical Assessment 
Patient data are shown in Table I. Fourteen patients took part in 
the study-7 males and 7 females. Acne was graded according to the 
involvement of back skin, using a 3-point scale-mild, moderate, or 
severe (modified from [14]). Informed and signed consent was obtained 
from all patients and the study was conducted with local ethical 
committee approval. 
Chemicals 
[7a-3H]-Dehydroepiandrosterone (13.9 Ci/rnmol) was obtained from 
the Radiochemical Centre, Amersham, England. Purity was checked 
by thin-layer chromatography (TLC) on Kieselgel HF60 254 ± 336 (E. 
Merck and Co., Darmstadt, West Germany) using chloroform/acetone 
185/15 (v/v) as solvent. Nicotinamide adenine dinucleotide (NAD+) 
and androstenedione were obtained from Sigma Chemical Company 
Limited, Kingston upon Thames, England. Organic solvents of analyt-
ical grade were used as supplied. 
Measurement of Sebum Excretion Rate (SER) 
SER was measured in 13 patients by a modification of the technique 
of Cunliffe, Kearney, and Simpson [15]. An area of clinically normal 
scapular skin 1.5 x 1.2 em (1.8 cm2 ) with an identifiable pilosebaceous 
orifice at the center was delineated by adhesive tape. Residual surface 
lipid was removed by the application of absorbent papers that were 
changed every 10 min until a pattern of lipid spots corresponding to 
individual sebaceous orifices (follicular pattern) could be seen. The area 
was protected from the rubbing of clothing and the patients rested for 
3 h during which time only cold drinks were allowed. After 3 h the 
accumulated lipid was sampled by the application of a finely ground 
glass plate and assayed by the use of a "Lipometre" (L'Oreal Labora-
tories, France). The .reading in millivolts was converted to Jig of lipid/ 
cm
2/3 h by 1·eference to a calibration curve. · 
Finely etched glass plates were used for this study. The sapphire 
sampling plates of Cunliffe et a\ [15] were found to be inaccurate on 
back skin as the surface lipid level of back skin is 10-fold less than that 
on the forehead. A calibration curve (Fig 1) was constructed using skin 
surface lipid eluted from the foreheads of 6 adult volunteers by diethyl 
ether; epithelial debris was removed by filtration and the lipid made up 
in serial dilutions in acetone. Ten microliter aliquots were dispensed 
onto the 1.8 cm2 plates, giving 10-80 11-g. em - 2 (6 replicates at each 
dilution). The acetone was allowed to evaporate, the sampling plates 
placed in the Lipometre, and the appropriate millivolt value recorded. 
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Biopsy and Sectioning of Tissues 
After sampling the skin surface lipid, the delineated area was anes-
thetized by subcutaneous injection oflignocaine (1% aqueous). A 4-mm 
punch biopsy, centered on the central pilosebaceous orifice, was taken 
and immediately frozen on solid C02• Specimens were stored overnight 
at -25°C, after which the subcutaneous fat was removed by naked eye 
dissection, the tissue embedded in ice, and sectioned on a cryostat at 
-25°C. Serial sections 16-Jiffi thick were cut and examined for the 
presence of sebaceous gland tissue. When sebaceous gland acini became 
visible, 10 consecutive sections were cut and alternate sections taken-
5 onto a microscope slide and 5 into an incubation tube at - 25°C. The 
procedure was repeated, until no sebaceous tissue could be identified, 
using fresh microscope slides and incubation tubes. This yielded 3-7 
incubations per biopsy. 
Histometry 
Tissue sections were fixed in formol saline and stained with hema-
toxylin and eosin. The thickness of the tissue section was measured at 
3 points by focusing on the extreme cell layers with a calibrated 
microscope stage, and the surface area measured by drawing using a 
Leitz Orthoplan microscope with drawing tube attachment and planim-
etry at 20x magnification for total section area and 125X magnification 
for sebaceous gland acini and pilosebaceous duct and sebaceous duct 
epithelium. One observer was used throughout. 
6."-3{1-HSD Assay 
The conversion of [7a -3H]DHA into [3H]-4-androstene-3,17-clione 
(also called [3H]-androstenedione) was measured by a modification of 
the methods of Shirley and Cook [16] and Chakraborty et al [13]. In 
the standard enzyme assay, 5 tissue sections were disintegrated by 
vortexing in 0.2 ml of a solution containing 0.1 JiM [7 a-3H]DHA, 0.6 mM 
NAD+, and 0.05 M Tris-HCl buffer, pH 7.6. The mixture was incubated 
for 60 min at 37°C, then the reaction was stopped by the addition of 2.0 
ml chloroform/methanol, 1/1 (v/v) containing nomadioactive DHA 
and androstenedione (400 Jig of each) as carriers. 
Two time courses were performed. In each, 65 tissue sections con-
taining sebaceous gland tissue were collected in a Teflon-glass homog-
enizer at -25°C and homogenized by hand in 1.0 ml of 0.05 Tris-HCl 
buffer, pH 7.6, for 10 min at 0°C on ice. Aliquots (0.1 ml) of the tissue 
homogenate were divided among 10 incubation tubes at 0°C. Reactions 
were started by adding 0.1 ml of 0.05 M Tris-HCl buffer, pH 7.6, 
containing 0.2 JiM [7a -3H]DHA and 1.2 mM NAD+. Duplicate incuba-
tions were performed in air at 37°C for 0, 15, 30, 60, and 120 min and 
were stopped as above. 
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FIG 1. Calibration curve for the "Lipometre." This curve is of the 
form y = A[1-e-B<• - •C> ], where A (the asymptotic value) = 400, B (the 
slope parameter) = 0.033, and C (the intercept on the ordinate) = 3.8. 
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TABLE II. Recrystallization of [ 3 H]-4-androstene-3,17-dione to 
constant specific activity" 
Specific activity 
Solvents 
Crystals Supernatant 
Acetone/n-hexane 
Acetone/n-hexane 
Chloroform/n-hexane 
Chloroform/n-hexane 
Acetone/n-hexane 
29,465 
28,659 
28,158 
28,745 
28,032 
" Theoretical sp act: 30,960 dpm/mg. 
Extraction and Isolation of Steroids 
38,274 
31,174 
30,765 
32,312 
28,780 
Reaction mixtures were evaporated to dryness at 40°C and parti-
tioned between diethyl ether and distilled water 8/1 (v/v). The ether 
fraction was taken to dryness under an air stream, the residue dissolved 
in a few drops of ethyl acetate/methanol 2/1 (v/v), and the steroids 
separated by TLC on silica gel HF60 254-366 using the solvent system, 
chloroform/acetone 185/15 (v/v). Carrier steroid bands were identified 
by fluorescence at 254 nm (androstenedione) and 366 nm (DHA), 
scraped from the plate into small glass columns, and the steroids eluted 
with 8 ml ethyl acetate/methanol, 2/1 (v/v). The eluates were taken to 
dryness under an air stream and dissolved in 2.0 ml methanol. Aliquots 
(0.2 ml) were added to 6 ml of a toluene scintillant containing 0.3% (w I 
v) 2,5-diphenyloxazole (PPO) and 0.01% (w /v) 1,4-di-2(4-methyl-5-
phenyloxazoyl}-benzene (POPOP) , in duplicate. Counting was per-
formed in a Packard Tri-carb liquid scintillation spectrometer model 
3214 with a counting efficiency of 42% for tritium. 
Statistical Analysis 
Linear regression has been calculated by the method of least squares. 
Significance testing of the correlation coefficients and of the difference 
between the intercept on the ordinate and zero were performed by the 
t-test. Partial correlation was calculated from the appropriate simple 
correlation coefficients. 
RESULTS 
Histometry 
There was no histologic evidence of pilosebaceous duct ob-
struction in any biopsy. Sebaceous gland area and section 
t hickness were measured on each section. The average section 
thickness was 16 J.lm ± 1.2 SD. The volume of sebaceous gland 
in a set of sections was the product of sebaceous gland area and 
average section thickness. Because alternate sections were 
taken for histometry and enzyme assay, it was assumed that 
t he volume of sebaceous gland in each enzyme assay was very 
similar to that in the corresponding sections taken for histo-
metry. The total volume of the sections from each biopsy 
ranged from 0.464- 0.949 mm3 (mean 0.633 ± 0.151 SD). There 
was no significant positive correlation between sebaceous gland 
volume and section volume, either in any single biopsy or when 
measurements from all sets of sections were pooled (r = 0.164, 
0.1 <p < 0.2, n = 85). 
Identification of Reaction Products 
After TLC about 3% of the applied radioactivity remained at 
t he origin of the chromatogram and 96% ± 1% SD was present 
in the DHA and androstenedione carrier bands. A pooled 
sample of eluted [3H)-4-androstene-3,17-dione was recrystal-
lized to constant specific activity from several solvents [8]. 
Table II shows that [3H)-4-androstene-3, 17 -dione was the major 
metabolite recovered from the incubations. The identity of 
e HJ-4-androstene-3,17-dione formed by incubation of [7a-3H] 
DHA with cryostat sections of human skin and NAD+ has been 
previously established [13]. 
Reproducibility of the Enzyme Assay 
The average recovery of radioactivity after the ether/water 
partition stage was 86.5% ± 5.0% SD. Radioactivity recovered 
in DHA and androstenedione fractions after TLC averaged 
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66.5% ± 6.9% SD of starting radioactivity. No correction for 
procedural losses was applied in calculating the quantity of 
CHJ-4-androstene-3,17-dione. 
Time Course of Conversion of {7a- 3H]DHA into ( JH]-4-
androstene-3, 17-dione 
Fig 2 shows 2 time courses and their respective controls over 
120 min. Reaction velocity is constant for up to 120 min and 
20% conversion of [7 a-3H]DHA into CHJ-4-androstene-3,17-
dione. 
Rate of Conversion of [7a-3H]DHA into fH]-4-androstene-
3,17-dione Compared with Sebaceous Gland Content of Skin 
Fig 3a shows the comparison between rate of [3H]-4-andros-
tene-3,17-dione formation and sebaceous gland volume for the 
85 individual incubations from 14 biopsies. Fig 3b shows the 
regression lines for comparison of rate of CHJ-4-androstene-
3,17-dione formation with sebaceous gland volume in the sets 
of 4-7 incubations from each biopsy; the appropriate correlation 
coefficients are shown in Table III. In all except 3 incubations 
the quantity of [3H]-4-androstene-3,17 -dione formed in 1 h fell 
within the linear part of the time course. It is clear that the 
rate of conversion of [7a-3H]DHA into androstenedione is di-
rectly proportional to sebaceous gland volume. In only 1 biopsy 
was the extrapolated intercept of the regression line at the 
ordinate significantly different from zero. In several incubations 
TABLE III. Significance levels for the correlations between rate of 
conversion of [7a-3H} DHA into {"H]-4-androstene-3,17-dione and 
sebaceous gland volume in each of 14 biopsies" 
Patient No. of Correlation incubations coefficient (r) 
1 7 0.83 (p < 0.05) 
2 7 0.95 (p < 0.001) 
3 5 0.64 (0.1 < p < 0.5) 
4 4 . 0.38 (0.6 <p < 0.7) 
5 7 0.70 (0.05 < p < 0.1) 
6 7 0.58 (0.1 < p < 0.5) 
7 7 0.72 (0.05 < p < 0.1) 
8 5 0.48 (0.1 <p < 0.5) 
9 7 0.92 (p < 0.01) 
10 7 0.93 (p < 0.01) 
11 6 0.99 (p < 0.001) 
12 7 0.90 (p < 0.01) 
13 6 0.84 (p < 0.05) 
14 4 0.99 (p < 0.01) 
" The linear regression lines are shown in Fig 3b. 
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FIG 4. The rate of conversion of [7a-~H]DHA into [3H]androstene-
dione in a biopsy as a function of sebaceous gland volume in 14 biopsies 
from 14 donors (r = 0.79; p < 0.001). 
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of [7a-~H]DHA into [3H]androstenedione in a biopsy (r = 0.78; p < 
0.01). Biopsies containing a single gland (filled circles); biopsies con-
taining several separate glands (open circles). Correlation for single 
glands only, r = 0.66 (p < 0.05). 
without histologically identifiable sebaceous gland in the sec-
tions there was no detectable formation of [3H]-4-androstene-
3,17 -dione. Similar results were obtained when sebaceous gland 
volume was calculated as a fraction of total section volume. 
There was no significant positive correlation betwe~n the rate 
of CHJ-4-androstene-3,17-dione formation and total section vol-
ume in any single biopsy or when results from all incubations 
were taken together (data not shown) . The results support the 
view that A5-3,8-HSD of human skin is localized mainly in 
sebaceous glands. 
Fig 4 shows the comparison between the rate of [:JH]-4-
androstene-3,17-dione formation in each biopsy (the sum of all 
incubations from the biopsy) and total sebaceous gland volume . 
Given that A5-3,8-HSD activity is localized in sebaceous glands, 
the positive linear correlation without significant intercept in-
dicates that, in the group of individuals studied, the specific 
activity of A5-3,8-HSD (rate of conversion of [7a-3H]DHA into 
[ 3H]-4-androstene-3,17 -dione per unit sebaceous gland volume) 
is relatively constant, i.e., there is no difference in specific 
activity between small and large glands. 
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Sebum Excretion Rate 
In the limited number of subjects studied there was no 
correlation between SER and the age, sex, or grade of acne of 
the patients. There was a highly significant positive correlation 
between SER and sebaceous gland volume (Fig 5) . Acini be-
longing to several separate sebaceous glands were identified in 
2 of the biopsies (open circles in Fig 5). When these were 
excluded a similar correlation was obtained. 
Sebum Excretion Rate and .6.5-3/J-HSD Activity 
Fig 6 shows that the rate of conversion of [7o:-3H]DHA into 
[ 3 H]-4-androstene-3,17-dione in a biopsy is positively correlated 
with SER measured in vivo over the biopsy site. The correlation 
remained if the 2 biopsies with several sebaceous glands were 
omitted. For each biopsy the specific activity of .6.5-3/J-HSD in 
the sebaceous glands was calculated by dividing the rate of 
formation of [3H]-4-androstene-3,17-dione by sebaceous gland 
volume. Fig 7 shows that there is no significant correlation 
between the specific activity of .6.5-3/J-HSD and SER. Again, 
omission of the 2 biopsies with several sebaceous glands did not 
ch ange the result. The same conclusion was reached by calcu-
lation of the partial correlation coefficients for SER and the 
rate of [3H]-4-androstene-3,17-dione formation from the simple 
correlation coefficients in Figs 4, 5, and 6, which gave a value 
T1.2.3 = 0.23. 
DISCUSSION 
Studies of body site variation in [13,17] and embryonic de-
velopment of [18] DHA metabolism in human skin suggest a 
sebaceous gland localization of .6.5-3/J-HSD-a conclusion drawn 
from histochemical studies of skin hydroxysteroid dehydrogen-
ases [9- 12,19]. However, the preferred 3/J-hydroxysteroid sub-
strate for the histochemical detection of hydroxysteroid dehy-
drogenase activity in human sebaceous glands is 3fJ-hydroxy-
5o:-androstan-3-one [9,12]; D. 4-5 -isomerase cannot be detected 
histochemically. Thus, even though biochemical analysis has 
demonstrated that DHA is converted into .6.4 -steroids in whole 
skin this does not necessarily confirm a sebaceous gland local-izati~n of the complete 3/J-hydroxysteroid dehydrogenase .6.4- 5-
isomerase complex. Nevertheless, it has now been shown that 
microdissected human sebaceous glands can convert DHA into 
.6.4-steroids and that in forehead skin the sebaceous gland is the 
main site of this reaction [20]. The present finding of direct 
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glands (open circles). Correlation for single glands only, r = 0.12; 0.7 
<p < 0.8) . 
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proportionality between the rate of conversion of DHA in_to 
androstenedione and sebaceous gland content of sets of senal 
sections within individual biopsies further strengthens the case 
that .6.5-3/J-HSD of back skin is a sebaceous gland enzyme. 
While this may turn out to be true for other body sites, 
conversion of DHA into .6.4-steroids has been demonstrated in 
plucked terminal hair follicles [21,22] and in axillary apocrine 
glands [20]. 
It appears that the concentration of enzyme in sebaceous 
glands (sp act = rate of androstenedione f?r~a~ion + s~baceous 
gland volume) did not differ among those ~divtduals wtth small 
and those with large sebaceous glands (Ftg 4). Yet there was a 
significant conelation between the rate of androstenedione 
formation in a biopsy and SER in male and female subjects. 
This results from the fact that .6.5-3/J-HSD is localized in seba-
ceous glands the size of which correlates with SER (Fig 5). 
When the specific activity of .6.5-3/J-HSD is compared with SER 
there is no significant correlation. Thus, the present study does 
not support the view that variation of .6.5-3,8-HSD concentration 
in sebaceous glands underlies interindividual variations in SER. 
.6.5-3,8-HSD could still play an important role in the andro-
genic control of sebum secretion. The temporal correlation 
between secretion of DHA [3,4] and the onset of sebaceous 
gland activity [5,6] suggests a role for this steroid in sebaceous 
gland physiology. A related steroid, .6.5 -androstene-3fJ,17 fJ-diol, 
is also an extremely potent stimulator of sebum secretion in the 
rat [23]. The sebotrophic effects of DHA and .6.5-androstene-
3fJ,17fJ-diol most probably require their conversion into testos-
terone or 5a-dihydrotestosterone; the first step in this transfor-
mation requires .6.5-3/J-HSD. However, it is likely that the flux 
through the pathway is controlled by supply of substrate rather 
than enzyme activity per se. Alternatively, it is possible that 
induction of .6.5-3,8-HSD in sebaceous glands takes place early 
in puberty (similarly to late fetal life [18,19]), reaching relatively 
constant levels in the adult. Thus it may be of interest to extend 
the present study to a younger age group. 
This study also emphasizes the importance (often over-
looked) of taking into account the cellular distribution of an 
enzyme when attempting to correlate its activity in an organ or 
tissue with some physiologic parameter or with a disease proc-
ess. Elevation of skin .6.5-3/J-HSD activity [24] or testosterone 
Sa-reductase [25,26] in hirsutism and acne could simply reflect 
the fact that both enzymes in skin are concentrated largely in 
sebaceous glands [20,27] which may be increased in size in the 
above disorders [28,29]. 
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The Hea~ing of Superficial Skin Wounds Is Stimulated by External 
Electrical Current 
OSCAR M. ALVAREZ, PH.D., PATRICIA M . MERTZ, B.A., RICHARD V. SMERBECK, B.S., AND 
WILLIAM H. EAGLSTEIN, M.D. 
Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, U.S.A. 
We studied the effects of direct electric current sup-
plied by an energized silver-coated electrode on dermal 
and epidermal wound healing. Keratome-induced 
wounds (0.3 mm deep) on the skin of young domestic 
pigs were treated with either an energized (50- 300 p.A) 
electrode (DC), an unenergized electrode (placebo), or 
left untreated. Wounds were excised on days 1-7 after 
wounding and the epidermis was separated from the 
dermis. The epidermal sheet was evaluated for reepithe-
lialization and the dermis was assayed for collagen bio-
synthetic capacity. Dermal collagen production among 
treatments did not differ markedly on days 1-4 after 
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Abbreviations: 
CFU: colony-forming units 
DC: direct electric current 
HTso: healing time for 50% of wounds 
TCA: trichloroacetic acid 
wounding. However, a highly significant increase (p < 
0.001) in the collagen synthetic capacity was observed 
on days 5, 6, and 7 in wounds treated with DC. There was 
no significant difference in collagen synthesis among 
treatments when collagen production was corrected for 
DNA content. The rate of wound epithelialization was 
also significantly accelerated (p < 0.05) in DC-treated 
wounds. These results suggest that the proliferative 
and/ or migratory capacity of epithelial and connective 
tissue cells involved in repair and regeneration can be 
affected by an electrical field. 
Recently the effect of electrical stimuli on tissues has been 
the subject of considerable experimental attention. Cells have 
complex electrical systems which are sensitive to electrical field 
changes. Varied effects, both specific and general, have been 
reported following electrical field alterations. Metabolic, behav-
ioral, physiologic, and immunologic changes, in a wide variety 
of systems including bacteria, insects, plants, and mammalian 
cells in culture have been observed after exposure to electric 
fields [ 1-7]. 
Electrically stimulated bone healing and regeneration has 
been reported by many investigators [8]. Direct current has 
